Skip to main content
. 2015 Jun 1;31(6):615–622. doi: 10.1089/aid.2014.0085

Table 2.

Participant Medications

UC participant number, medications HIVDVL participant number, medications HIVNDVL participant number, medications
1 Dicyclomine, metronidazole, prednisone 1 Lamivudine, nevirapine, tenofovir DF 1 Lamivudine/zidovudine, saquinavir, ritonavir, nevirapine
2 5-ASA, prednisone, AZA, fludrocortisone 2 5-ASA, lamivudine/zidovudine, tenofovir DF, efavirenz 2 Lamivudine, lopinavir/ritonavir, tenofovir DF
3 Infliximab 3 5-ASA, lamivudine/zidovudine, tenofovir DF, efavirenz 3 Abacavir/lamivudine/zidovudine, tenofovir DF
4 Infliximab, prednisone 4 No medications 4 Lamivudine/zidovudine, efavirenz, acyclovir
5 Unknown 5 No medications 5 No medications
6 5-ASA 6 Emtricitabine/tenofovir DF/efavirenz 6 Raltegravir, lopinavir/ritonavir, etravirine
7 5-ASA 7 No medications 7 Lamivudine, didanosine, nevirapine, stavudine
8 Fish oil 8 No medications 8 Lamivudine/zidovudine, saquinavir, nelfinavir
9 5-ASA, prednisone, 6-MP 9 Lopinavir/ritonavir, tenofovir DF, abacavir 9 Lamivudine, stavudine, tenofovir DF
    10 Lopinavir/ritonavir, lamivudine 10 Lamivudine, stavudrine, efavirenz

HIV-infected participants were stratified according to detectable plasma viral load (HIVDVL) vs. nondetectable plasma viral load (HIVNDVL).

5-ASA, 5-aminosalicylic acid; AZA, azathioprine; 6-MP, 6-mercaptopurine; DF, disoproxil fumarate.